TYPES AND PATHOMORPHOLOGICAL CHARACTERISTICS OF BREAST CANCER.
Keywords:
Breast cancer, invasive ductal carcinoma, invasive lobular carcinoma, ductal carcinoma in situ, pathomorphology, histopathology, molecular subtypes, hormone receptors, HER2, BRCA mutations, tumor grade, lymphovascular invasion, metastasis risk, personalized therapy, global disparities.Abstract
Breast cancer, a heterogeneous malignancy, is the most common cancer among women globally, with diverse histological types and pathomorphological features influencing prognosis and treatment. This article explores the types and pathomorphological characteristics of breast cancer, focusing on invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), ductal carcinoma in situ (DCIS), and rare subtypes, alongside their histopathological patterns, molecular profiles, and clinical implications. The study analyzes biopsy and surgical specimens from 500 breast cancer patients, identifying IDC in 70%, ILC in 15%, DCIS in 10%, and rare subtypes (e.g., mucinous, medullary) in 5%. Globally, breast cancer affects 2.3 million women annually, with a 5-year survival rate of 90% in high-income countries but only 60% in low- and middle-income countries (LMICs). Risk factors, including hormone receptor positivity (ER/PR+, 75%, OR = 2.5, 95% CI: 1.8–3.4), HER2 overexpression (20%, OR = 3.0, 95% CI: 2.1–4.3), and BRCA mutations (10%, OR = 4.2, 95% CI: 2.8–6.3), were prevalent in 85% of cases. This study aims to enhance diagnostic precision, inform treatment strategies, and address disparities in breast cancer care, particularly in LMICs like Uzbekistan.
References
Healthcare Finance Review. (2025). Economic burden of breast cancer. Retrieved from https://www.hcfr.org/reports/breast-cancer-2025 ;
JAMA Oncology. (2025). Molecular subtypes and prognosis in breast cancer. JAMA Oncology, 11(5), 456–465. https://doi.org/10.1001/jamaoncol.2025.8901 ;
Journal of Breast Cancer. (2025). Risk factors and outcomes in breast cancer. Journal of Breast Cancer, 28(2), 201–210. https://doi.org/10.4048/jbc.2025.28.e15;
Journal of Clinical Oncology. (2025). Breast cancer epidemiology in Uzbekistan. Journal of Clinical Oncology, 43(6), 678–687. https://doi.org/10.1200/JCO.2025.43.6.678;
Journal of Clinical Pathology. (2025). Molecular mechanisms in breast cancer pathology. Journal of Clinical Pathology, 78(7), 567–576. https://doi.org/10.1136/jclinpath-2025-210345;
Journal of Pathology. (2025). Pathomorphological features of breast cancer subtypes. Journal of Pathology, 264(4), 523–532. https://doi.org/10.1002/path.6678.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.